Alpha IVF Group Berhad (KLSE:ALPHA)

Market Cap	1.16B -14.6%
Revenue (ttm)	196.52M +13.2%
Net Income	55.80M +0.7%
EPS	0.01 +0.9%
Shares Out	4.84B
PE Ratio	20.94
Forward PE	20.87
Dividend	0.01 (4.08%)
Ex-Dividend Date	Mar 18, 2026

Volume	641,500
Open	0.2400
Previous Close	0.2400
Day's Range	0.2400 - 0.2450
52-Week Range	0.2350 - 0.3450
Beta	0.21
Analysts	Strong Buy
Price Target	0.35 (+42.86%)
Earnings Date	Jul 17, 2026

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation op...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 198
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In fiscal year 2025, Alpha IVF Group Berhad's revenue was 176.84 million, an increase of 5.52% compared to the previous year's 167.59 million. Earnings were 57.45 million, an increase of 8.54%.

Analyst Summary

According to 2 analysts, the average rating for ALPHA stock is "Strong Buy." The 12-month stock price target is RM 0.35, which is an increase of 42.86% from the latest price.

Price Target

RM 0.35

(42.86% upside)

Analyst Consensus: Strong Buy